Krakauer Marcio, Gómez Ana M, Almeda-Valdes Paloma, Manrique Helard, Ruiz Morosini María Lidia, Godoy Jorquera Gonzalo, Nunes Salles João Eduardo, Sanhueza Costa David, de Azeredo Siqueira Rodrigo, Faradji Raquel N, Rincón Ramírez Alex, Ré Matías, Fériz Bonelo Karen, Proietti Adrián, Lavalle-González Fernando J
Sociedade Brasileira de Diabetes, São Paulo, Brazil.
Pontifical Javeriana University, Bogotá, Colombia.
Diabetol Metab Syndr. 2024 May 20;16(1):106. doi: 10.1186/s13098-024-01343-7.
To establish recommendations through the consensus of a Latin American experts panel on the use of the flash glucose monitoring system (fCGM) in people living with type 2 diabetes mellitus (T2DM) regarding the benefits and challenges of using the fCGM.
An executive committee of experts was created, comprised by a panel of fifteen physicians, including endocrinologists and internal medicine physicians, with expertise in management of adult patients with T2DM. The experts were from various countries: Colombia, Chile, Peru, Mexico, Argentina, and Brazil. The modified Delphi method was used, considering a consensus level of at least 80% of the participants. A seventeen-item instrument was developed to establish recommendations on the use of fCGM in patients with T2DM in Latin American.
The number of glucose scans recommended per day with the fCGM for patients managed with oral antidiabetic drugs or basal insulin was a median of 6 scans per day, and for those managed with multiple insulin doses, a median of 10 scans per day was recommended. Additionally, a holistic and individualized management approach was recommended, taking into account new treatment directions and identifying patients who would benefit from the use of the fCGM.
Continuous use of the fCGM is recommended for people living with T2DM, regardless of their type of treatment. These metrics must be evaluated individually for each patient profile.
通过拉丁美洲专家小组的共识，就2型糖尿病（T2DM）患者使用动态血糖监测系统（fCGM）的益处和挑战建立相关建议。
成立了一个专家执行委员会，由15名医生组成的小组构成，包括内分泌科医生和内科医生，他们在成年T2DM患者管理方面拥有专业知识。专家来自不同国家：哥伦比亚、智利、秘鲁、墨西哥、阿根廷和巴西。采用改良的德尔菲法，将至少80%的参与者达成共识作为标准。开发了一份包含17个条目的工具，以建立关于拉丁美洲T2DM患者使用fCGM的建议。
对于使用口服降糖药或基础胰岛素治疗的患者，fCGM推荐的每日血糖扫描次数中位数为每天6次扫描，对于使用多次胰岛素剂量治疗的患者，推荐的每日扫描次数中位数为每天10次。此外，建议采用全面且个性化的管理方法，考虑新的治疗方向并确定能从使用fCGM中获益的患者。
建议T2DM患者持续使用fCGM，无论其治疗类型如何。这些指标必须针对每个患者的具体情况进行单独评估。
